Praxis Precision Medicines
Last updated: August 13, 2024
Marcio Souza, CEO
USA | Funding: $573.1M (+)
Website: https://www.praxismedicines.com/
Praxis is a clinical-stage genetic neuroscience company that develops high-impact therapies for patients and families affected by complex and debilitating brain disorders
Website: https://www.praxismedicines.com/
Praxis is a clinical-stage genetic neuroscience company that develops high-impact therapies for patients and families affected by complex and debilitating brain disorders